Copyright © 1993 by the European Society of Cardiology.
© 1993 The European Society of Cardiology
Coronary artery disease after heart transplantation: non-invasive evaluation with exercise thallium scintigraphy
Department of Cardiology A. De Gasperis, Ospedale Ca' Granda Milan, Italy
*Department of Nuclear Medicine, Ospedale Ca' Granda Milan, Italy
Received 24 February 1992; revised 17 August 1992; .
Correspondence: Guglielma R Ciliberto, MD. Via E. De Marchi 8. 20125 Milano. Italy
Abstract
In order to assess the value of exercise thallium scintigraphy for the detection and prognosis of graft coronary artery disease, 50 heart transplant patients (mean age 46.7 ± 11.5 years) were studied within 48 h of their scheduled yearly coronary angiography and subsequently followed up for a mean of 13 ± 3 months. Angiography revealed normal coronary arteries in 35 patients, and coronary artery disease in 15 (two with type A lesions, seven with type B lesions and six with both). Seven patients had one or more stenoses
50%. Exercise thallium scintigraphy was negative in all patients with normal coronary arteries (100% specificity), and abnormal in 10 of 15 patients with coronary artery disease (67% sensitivity). Fixed defects were seen in six cases, transient defects in two and both in two, the results of the test were abnormal in all seven patients with
50% lesions.
During follow-up, none of the patients with a normal exercise thallium scintigraphy experienced any cardiac event; in the group with abnormal results, four cardiac events occurred. Although further studies are needed to confirm these results, exercise thallium scintigraphy seems to be useful in evaluating post-transplant coronary artery disease: it is accurate in detecting the most severe stenoses and provides some prognostic information.
Key Words: Heart transplantation coronary artery disease non-invasive tests exercise thallium scintigraphy
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. D. Estep, D. J. Shah, S. F. Nagueh, J. J. Mahmarian, G. Torre-Amione, and W. A. Zoghbi The Role of Multimodality Cardiac Imaging in the Transplanted Heart J. Am. Coll. Cardiol. Img., September 1, 2009; 2(9): 1126 - 1140. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Tuzcu, S. R. Kapadia, R. Sachar, K. M. Ziada, T. D. Crowe, J. Feng, W. A. Magyar, R. E. Hobbs, R. C. Starling, J. B. Young, et al. Intravascular Ultrasound Evidence of Angiographically Silent Progression in Coronary Atherosclerosis Predicts Long-Term Morbidity and Mortality After Cardiac Transplantation J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1538 - 1542. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.R Ciliberto, L Ruffini, M Mangiavacchi, M Parolini, R Sara, D Massa, R De Maria, E Gronda, E Vitali, and O Parodi Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation Eur. Heart J., June 1, 2001; 22(11): 964 - 971. [Abstract] [PDF] |
||||
![]() |
R. Lamich, M. Ballester, V. Marti, V. Brossa, R. Aymat, I. Carrio, L. Berna, M. Camprecios, M. Puig, M. Estorch, et al. Efficacy of augmented immunosuppressive therapy for early vasculopathy in heart transplantation J. Am. Coll. Cardiol., August 1, 1998; 32(2): 413 - 419. [Abstract] [Full Text] [PDF] |
||||


